Blood Collection Devices Market Size, Share, Trends, Analysis and Growth 2030

Blood Collection Devices Market Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Blood Collection Sets, Blood Collection Needles/Holders, Blood Collection Tubes, Others), Method (Manual Blood Collection, Automated Blood Collection), End User (Hospitals and Pathology Laboratories, Blood Banks, Others), and Geography

  • Report Code : TIPHE100001279
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 176

Blood Collection Devices Market Forecast (2022-2030)

Buy Now

The blood collection devices market size is projected to reach US$ 14,021.79 million by 2030 from US$ 8,713.21 million in 2022. The market is expected to register a CAGR of 6.1% during 2022–2030. Technological developments in blood collection techniques and products are likely to remain a key trend in the market.

Blood Collection Devices Market Analysis

Blood sampling is an essential part of many disease diagnoses. It is the first step in diagnosing any illness in the body and not only aids in learning about the excess or deficiency of different elements in the body. Hospitals and medical facilities can choose from a variety of blood collection systems. Thus, various key players such as Becton Dickinson and Co, Terumo Corp, Cardinal Health Inc., SARSTEDT AG & Co KG, Nipro Corp, Thermo Fisher Scientific Inc., and others are engaged in offering a significant product portfolio for blood collection devices.

Blood Collection Devices Market Overview

Globally, medical facilities are witnessing a significant rise in the incidence of cancer. The National Cancer Institute states that cancer is becoming a more significant global health concern. Around 10 million people worldwide lost their lives to cancer in 2020, with 19.3 million new cases reported. According to the WHO (World Health Organization), there may be approximately 28.9 million new cases of cancer worldwide by 2040. Liquid biopsies, the most popular type of blood test for cancer, are used to screen for and diagnose cancers, including ovarian, breast, colorectal, prostate, and non-small cell lung cancer (NSCLC). Blood collection tubes thus support the organization's early cancer detection strategy, facilitating prompt treatment and raising the survival rates of cancer patients. Thus, the global market for blood collection devices is driven by the rising incidence of cancer.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Blood Collection Devices Market: Strategic Insights

Blood Collection Devices Market
  • CAGR
    CAGR (2022 - 2030)
    6.1%
  • Market Size 2022
    US$ 8,713.21 Million
  • Market Size 2030
    US$ 14,021.79 Million

Market Dynamics

GROWTH DRIVERS
  • An Increase in Demand for advanced Diagnostics Tests for infectious diseases
FUTURE TRENDS
  • Introduction of Technologically Advanced Products
OPPORTUNITIES
  • A Rise in the Prevalence of Chronic Diseases

Key Players

  • Becton Dickinson and Co
  • Terumo Corp
  • Cardinal Health Inc
  • SARSTEDT AG Co KG
  • Nipro Corp
  • Sekisui Chemical Co Ltd
  • Thermo Fisher Scientific Inc
  • Greiner Bio One International GmbH
  • FL Medical SRL
  • IntervacTechnology OU

Regional Overview

Regional Overview
  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Market SegmentProduct
  • Blood Collection Tubes
  • Blood Collection Needles/Holders
  • Blood Collection Sets
Market SegmentApplication
  • Arthroplasty
  • Kyphoplasty
  • Vertebroplasty
Market SegmentEnd User
  • Hospitals
  • Ambulatory Surgery Centers
  • Clinics
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Blood Collection Devices Market Drivers and Opportunities

Increase in Demand for Minimally Invasive Diagnostics Tests Favors the Market Growth

Due to less pain and wounding than traditional venipuncture, minimally invasive sampling techniques like capillary blood sampling are frequently utilized for point-of-care testing in clinical settings like the ICU and home healthcare settings. Patients are increasingly choosing minimally or noninvasive tests when seeking a diagnosis.  In recent times, there has been a lot of interest in the noninvasive blood collection procedure due to technological advancements that have improved processing times and feasibility. A blood test lowers the cost and duration of problem diagnosis while being a noninvasive, painless procedure. A blood test is a straightforward substitute for surgical biopsies that allows medical professionals to know more about tumors from a straightforward blood sample. Therefore, the increase in the demand for noninvasive or minimally invasive diagnostic tests is driving the growth of the global market for blood collection devices.

Introduction of Technologically Advanced Products

Blood collection from patients with DVA (difficult venous access) presents a challenge. In the case of DVA patients, the traditional blood collection device is frequently unable to collect adequate samples, resulting in multiple attempts to collect blood. Repeated attempts may result in anemia, as well as the transmission of blood-borne pathogens to nurses. To avoid such scenarios, market players have introduced novel hematology tube designs that facilitate capillary blood collection while lowering the risks of blood collection and treatment errors in DVA patients. The new technology provides a painless, needle-free, and user-friendly method for collecting blood samples. The system enables blood samples to be collected in a minimally invasive manner. Hematology tubes, which are placed on a patient's upper arm, improve capillary blood flow beneath the skin using micro-incision and patented skin vasodilation technology. For instance, Vitestro, a Dutch medical robotics company, unveiled the world's most advanced autonomous blood drawing device at the Netherlands Society for Clinical Chemistry and Laboratory Medicine's (NVKC) annual meeting in Rotterdam in May 2022. Vitestro's device combines Al-based, ultrasound-guided 3D reconstruction with robotic needle insertion for precise and secure blood collection.

Blood Collection Devices Market Report Segmentation Analysis

Key segments that contributed to the derivation of the blood collection devices market analysis are product, method, and end user.

  • Based on product, the blood collection devices market is segmented into blood collection tubes, blood collection needles/holders, blood collection sets, others. The blood collection tubes segment held the most significant market share in 2022.
  • By method, the market is categorized into manual blood collection, automated blood collection. The manual blood collection segment held the largest share of the market in 2022.
  • By end user, the market is segmented into hospitals and pathology laboratories, blood banks, others. The hospitals and pathology laboratories segment held the largest share of the market in 2022.

Blood Collection Devices Market Share Analysis by Geography

The geographic scope of the blood collection devices market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

The healthcare industry in the United States is well-developed, with cutting-edge technology and instruments. The country is seeing an increase in chronic diseases such as acute kidney injury (AKI), multiple organ dysfunction syndromes, and sepsis, which is expected to boost the blood collection device market. The Centers for Disease Control and Prevention's "Chronic Kidney Disease in the United States, 2023" report estimates that 14% of the US population (35.5 million) has chronic kidney disease (CKD). Furthermore, nine out of ten people are unaware that they have chronic kidney disease. The causes of CKD include hypertension, heart disease, obesity, and diabetes. As a result, the prevalence of high blood pressure, heart disease, diabetes, and obesity has risen in the United States, thereby causing a demand for blood samples for diagnostics and research, propelling the growth of the North American blood collection device market.

Blood Collection Devices Market Report Scope

Report Attribute Details
Market size in 2022 US$ 8,713.21 Million
Market Size by 2030 US$ 14,021.79 Million
Global CAGR (2022 - 2030) 6.1%
Historical Data 2020-2021
Forecast period 2022-2030
Segments Covered By Product
  • Blood Collection Tubes
  • Blood Collection Needles/Holders
  • Blood Collection Sets
By Application
  • Arthroplasty
  • Kyphoplasty
  • Vertebroplasty
By End User
  • Hospitals
  • Ambulatory Surgery Centers
  • Clinics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Becton Dickinson and Co
  • Terumo Corp
  • Cardinal Health Inc
  • SARSTEDT AG Co KG
  • Nipro Corp
  • Sekisui Chemical Co Ltd
  • Thermo Fisher Scientific Inc
  • Greiner Bio One International GmbH
  • FL Medical SRL
  • IntervacTechnology OU
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Blood Collection Devices Market News and Recent Developments

The blood collection devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the blood collection devices market are listed below:

  • BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced it has received 510(k) clearances from the U.S. Federal Drug Administration (FDA) for a novel blood collection device that obtains blood samples from a fingerstick that produce lab-quality results for some of the most commonly ordered blood tests. (Source: BD, Press Release, December 2023)
  • ASP Global, a leading strategic sourcing company serving America’s largest health systems, labs and distributors, announced the acquisition of Nashville-headquartered, RAM Scientific. RAM Scientific has provided high quality 100% plastic capillary blood collection devices since 1989, and is recognized as the premiere source of safe micro blood collection systems for clinical and research applications. The acquisition supports ASP Global’s focus on expanding its supply chain capabilities, and providing comprehensive, clinically relevant and specialized solutions to customers and patients. (Source: ASP Global, Press Release, December 2022)

Blood Collection Devices Market Report Coverage and Deliverables

The “Blood Collection Devices Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:

  • Blood collection devices market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Blood collection devices market trends as well as market dynamics such as drivers, restraints, and key opportunities
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Blood collection devices market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
  • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the blood collection devices market
  • Detailed company profiles
Report Coverage

Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered

Segment Covered

Product, Method, and End User

Regional Scope

Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope

Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which are the leading players operating in the blood collection devices market?

Becton Dickinson and Co, Terumo Corp, Cardinal Health Inc, SARSTEDT AG & Co KG, Nipro Corp, Sekisui Chemical Co Ltd, Thermo Fisher Scientific Inc, Greiner Bio-One International GmbH, FL Medical SRL, IntervacTechnology OU

What is the expected CAGR of the blood collection devices market?

The market is expected to register a CAGR of 6.1% during 2022–2030.

Which region dominated the blood collection devices market in 2022?

North America dominated the blood collection devices market in 2022

What are the driving factors impacting the blood collection devices market?

Key factors driving the market are an increase in demand for minimally invasive diagnostics tests and a rise in the prevalence of chronic diseases.

What are the future trends of the blood collection devices market?

Technological developments in blood collection techniques and products are likely to remain a key trend in the market.

The List of Companies - Blood Collection Devices Market

  1. Becton Dickinson and Co
  2. Terumo Corp  
  3. Cardinal Health Inc  
  4. SARSTEDT AG & Co KG
  5. Nipro Corp  
  6. Thermo Fisher Scientific Inc
  7. Sekisui Chemical Co Ltd
  8. Greiner Bio-One International GmbH  
  9. FL Medical SRL
  10. IntervacTechnology OU

Trends and growth analysis reports related to Medical Device : READ MORE..